Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies

F. J. Giles*, N. Vey, D. Rizzieri, F. Ravandi, T. Prebet, G. Borthakur, T. F. Jacobsen, S. Hagen, B. Nilsson, S. O'Brien

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)1686-1689
Number of pages4
Issue number7
StatePublished - Jul 2012

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this